TR200003443T2 - Geçmeyen depresyonun tedavisi için kombinasyon terapisi - Google Patents

Geçmeyen depresyonun tedavisi için kombinasyon terapisi

Info

Publication number
TR200003443T2
TR200003443T2 TR2000/03443T TR200003443T TR200003443T2 TR 200003443 T2 TR200003443 T2 TR 200003443T2 TR 2000/03443 T TR2000/03443 T TR 2000/03443T TR 200003443 T TR200003443 T TR 200003443T TR 200003443 T2 TR200003443 T2 TR 200003443T2
Authority
TR
Turkey
Prior art keywords
treatment
depression
impressive
combination therapy
activity
Prior art date
Application number
TR2000/03443T
Other languages
English (en)
Turkish (tr)
Inventor
Dennis Tollefson Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200003443T2 publication Critical patent/TR200003443T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Oxide Ceramics (AREA)
TR2000/03443T 1998-05-22 1999-05-21 Geçmeyen depresyonun tedavisi için kombinasyon terapisi TR200003443T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8644498P 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
TR200003443T2 true TR200003443T2 (tr) 2001-03-21

Family

ID=22198612

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03443T TR200003443T2 (tr) 1998-05-22 1999-05-21 Geçmeyen depresyonun tedavisi için kombinasyon terapisi

Country Status (24)

Country Link
EP (1) EP0958824A3 (https=)
JP (1) JP2002516282A (https=)
KR (1) KR20010043730A (https=)
CN (1) CN1154496C (https=)
AU (1) AU761510B2 (https=)
BR (1) BR9911049A (https=)
CA (1) CA2332814C (https=)
CZ (1) CZ20004279A3 (https=)
EA (1) EA004539B1 (https=)
HK (1) HK1040055B (https=)
HR (1) HRP20000797A2 (https=)
HU (1) HUP0101901A3 (https=)
ID (1) ID26861A (https=)
IL (1) IL139592A (https=)
MY (1) MY127938A (https=)
NO (1) NO20005885L (https=)
NZ (1) NZ507980A (https=)
PL (1) PL344331A1 (https=)
SK (1) SK17512000A3 (https=)
TR (1) TR200003443T2 (https=)
TW (1) TWI226829B (https=)
UA (1) UA78181C2 (https=)
WO (1) WO1999061027A1 (https=)
ZA (1) ZA200006815B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1133299A1 (en) * 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
EP1396267A3 (en) * 1999-12-06 2004-04-21 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
CA2431041A1 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
CA2529857A1 (en) 2002-07-30 2004-02-05 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
GB0229583D0 (en) * 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
KR100842694B1 (ko) 2002-12-27 2008-07-01 오쓰까 세이야꾸 가부시키가이샤 기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
WO2005023243A1 (en) * 2003-09-04 2005-03-17 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and loxapine
ES2319539T3 (es) 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005056056A2 (en) * 2003-12-15 2005-06-23 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
EP2275095A3 (en) * 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
PL2044043T5 (pl) 2006-06-16 2022-05-02 H. Lundbeck A/S Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych
PL2120878T3 (pl) * 2007-02-09 2015-01-30 Alphapharm Pty Ltd Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
TWI432194B (zh) * 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN105769875A (zh) * 2014-12-22 2016-07-20 扬子江药业集团上海海尼药业有限公司 复方奥氮平盐酸氟西汀胶囊的制备方法
CN108938645A (zh) * 2018-08-24 2018-12-07 山西医科大学第医院 一种抗精神病药物组合物
CN111084778B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种奥氮平盐酸氟西汀胶囊及其制备方法
CN114569566A (zh) * 2020-12-02 2022-06-03 四川科瑞德制药股份有限公司 一种盐酸米那普仑制剂的制备方法
ES3054324A1 (es) * 2024-07-12 2026-02-02 Univ Malaga Galanina (1-15) y Fluoxetina en el tratamiento de la depresión resistente al tratamiento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
HUP9903679A3 (en) * 1996-03-11 2001-10-29 Lilly Co Eli Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
MY127938A (en) 2007-01-31
EA200001218A1 (ru) 2001-06-25
ID26861A (id) 2001-02-15
WO1999061027A1 (en) 1999-12-02
EA004539B1 (ru) 2004-06-24
NZ507980A (en) 2003-10-31
HK1040055A1 (en) 2002-05-24
SK17512000A3 (sk) 2002-02-05
IL139592A (en) 2005-08-31
CZ20004279A3 (cs) 2001-09-12
PL344331A1 (en) 2001-11-05
UA78181C2 (en) 2007-03-15
CA2332814A1 (en) 1999-12-02
KR20010043730A (ko) 2001-05-25
JP2002516282A (ja) 2002-06-04
CN1311681A (zh) 2001-09-05
EP0958824A2 (en) 1999-11-24
AU761510B2 (en) 2003-06-05
HUP0101901A2 (hu) 2001-11-28
IL139592A0 (en) 2002-02-10
CN1154496C (zh) 2004-06-23
BR9911049A (pt) 2001-02-06
AU4008699A (en) 1999-12-13
HRP20000797A2 (en) 2001-10-31
HUP0101901A3 (en) 2002-06-28
TWI226829B (en) 2005-01-21
EP0958824A3 (en) 1999-12-01
ZA200006815B (en) 2002-01-14
HK1040055B (zh) 2005-04-01
CA2332814C (en) 2008-11-04
NO20005885D0 (no) 2000-11-21
NO20005885L (no) 2001-01-17

Similar Documents

Publication Publication Date Title
TR200003443T2 (tr) Geçmeyen depresyonun tedavisi için kombinasyon terapisi
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
DK1558616T4 (da) Meso-substituerede porphyriner
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
PT1068870E (pt) Agentes antitumorais
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
MX9702170A (es) Uso de inhibidores de la aromatasa para la produccion de un agente farmaceutico para el tratamiento de una deficiencia de androgeno relativa en los hombres.
DE60121440D1 (de) Krebsbehandlung zusammensetzung, welche ein antineoplastisches mittel und pde4 inhibitor enthält
BR0010702A (pt) Novas quinonas como terapias de doenças
ES2163795T3 (es) Composicion farmaceutica contra los tumores e infecciones por papilomavirus.
NO994330D0 (no) Metode for behandling av en tumor
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
ATE418613T1 (de) Antimikrobielle zusammensetzungen
EA200300572A1 (ru) Комбинированная терапия эстроген-зависимых заболеваний
ATE231510T1 (de) Penamsulfone als beta-laktamase inhibitoren
DE60143681D1 (de) Kombinationstherapie gegen Tumoren mit substituierten Acryloyl-Distamycin-Derivaten, Taxanen und/oder Antimetaboliten
DE60318561D1 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivaten und radiotherapie
RU94024337A (ru) Антиметастатическое средство
EA200200321A1 (ru) Апоптин-ассоциированный белок
ES2170479T3 (es) Agente viral terapeutico que detiene el desarrollo de tumores.
ECSP003812A (es) Compuestos de dihidropirimidina hererociclicos
ECSP003445A (es) Pirazolbenzodiazepinas